XIENCE PRIME Adverse Events: FDA MAUDE Data
ABBOTT VASCULAR INC. · Coronary Drug-Eluting Stent · First cleared Oct 2012
Total Reports
1,187
Reports (30d)
4
Active Signals
0
Open Recalls
0
What the reports describe · Claripulse analysis
Most commonly reported problems
Polymer-Free Stent Safety Outcomes
outcomes, polymer, article, patients, years
4
reports
Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.
Evidence
Related research
Procedural Characteristics of Intravascular Ultrasound–Guided Percutaneous Coronary Intervention and Their Clinical Implications
Seung‐Yul Lee, et al. · Journal of the American Heart Association · 2022
Impact of Intravascular Ultrasound–Guided Optimal Stent Expansion on 3-Year Hard Clinical Outcomes
Yong‐Joon Lee, et al. · Circulation Cardiovascular Interventions · 2021
Citations indexed from PubMed.
Keep exploring
Related devices in Coronary
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,635 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,655 reports
PERCLOSE
ABBOTT VASCULAR INC. · 10,082 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,727 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 6,095 reports
Resolute Onyx
MEDTRONIC, INC. · 4,494 reports
Want automated safety signal detection?
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.
Get Early AccessUnderstanding this data